[1]
Kinos, S. et al. 2024. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study). Acta Oncologica. 63, 1 (May 2024), 248–258. DOI:https://doi.org/10.2340/1651-226X.2024.24023.